COPD – Page 2 – Medxy AI

Vitamin D Deficiency and Accelerated Bone Loss in Mild to Moderate COPD: New Insights from the Multi-Ethnic Study of Atherosclerosis

By MedXY 08/06/2025

Mild to moderate COPD accelerates vertebral bone mineral density loss only in individuals with vitamin D deficiency, highlighting a modifiable risk factor for osteoporosis in this population.

Clinical Updates news Respiratory Specialties

AI-Enhanced Spirometry Interpretation in Primary Care: Evidence from a Randomized Controlled Trial

By MedXY 08/05/2025

AI decision support significantly improves primary care clinicians’ accuracy in spirometry diagnosis, especially for COPD, addressing a key gap in respiratory disease management.

Clinical Updates news Respiratory Specialties

Young COPD: Prevalence and Prognostic Impact in Adults Under 50 Years

By MedXY 08/05/2025

COPD in adults under 50 affects 4.5% of this population and is linked to increased risks of early mortality and serious cardiopulmonary events, underscoring the need for early identification and intervention.

Clinical Updates Respiratory Specialties

Type 2 Inflammation Biomarkers and Dupilumab Response in COPD: Insights from the BOREAS Phase 3 Trial

By MedXY 08/02/2025

Dupilumab significantly reduced type 2 inflammation biomarkers and exacerbation risk in COPD patients with elevated eosinophils, highlighting the value of biomarker-driven therapy.